Option Fund
Prof. Spyros Artavanis-Tsakonas
Chairman
Department of Cell Biology, Harvard Medical School, Boston, USA
Prof. Joan S. Brugge
Chair of Department of Cell Biology, Harvard Medical School, Boston, USA
Prof. Dr. Daniel Louvard
Director of the Research, Institut Curie, Paris, France
Prof. Hidde Ploegh
Professor of Biology, Massachusetts Institute of Technology.
Member, Whitehead Institute for Biomedical Research
In addition the following people are supporting
the Novartis Option Fund Board:
Anthony Rosenberg
Global Head of BD&L, Novartis Pharma
Dr. Charles Wilson
Global Head of Strategic Alliance, NIBR
Dr. Reinhard Ambros
Head of Novartis Venture Funds